Expression of girdin in human colorectal cancer and its association with tumor progression

Diseases of the Colon and Rectum

Volumn 56, Issue 1, 2013, Pages 51-57

  Jun, Byoung Yeon ^a   Kim, Sang Woo ^a,b   Jung, Chan Kwon ^a   Cho, Yu Kyung ^a   Lee, In Seok ^a   Choi, Myung Gyu ^a   Choi, Kyu Yong ^a   Oh, Seong Taek ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Colorectal cancer; Girdin protein; Human; Immunohistochemistry; Microarray analysis; Neoplasm invasiveness

Indexed keywords

GIRDIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL SURGERY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STAINING; TERTIARY HEALTH CARE; TISSUE MICROARRAY; TUMOR BIOPSY;

AGED; BIOPSY; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEDICAL RECORDS, PROBLEM-ORIENTED; MICROFILAMENT PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROTEIN ARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS; REPUBLIC OF KOREA; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; VESICULAR TRANSPORT PROTEINS;

EID: 84872190347     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e31826b9b7e     Document Type: Article

References (25)

1. Müller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50-56 (Pubitemid 32225831)
2. Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene. 2005;24:7443-7454 (Pubitemid 41637984)
3. Qiao M, Iglehart JD, Pardee AB. Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activation. Cancer Res. 2007;67:5293-5299 (Pubitemid 46997268)
4. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003;3:453-458 (Pubitemid 37328849)
5. Qiao M, Sheng S, Pardee AB. Metastasis and AKT activation. Cell Cycle. 2008;7:2991-2996
6. Garcia-Marcos M, Ghosh P, Farquhar MG. GIV is a nonreceptor GEF for G alpha i with a unique motif that regulates Akt signaling. Proc Natl Acad Sci USA. 2009;106:3178-3183
7. Garcia-Marcos M, Ghosh P, Ear J, Farquhar MG. A structural determinant that renders G alpha(i) sensitive to activation by GIV/girdin is required to promote cell migration. J Biol Chem. 2010;285:12765-12777
8. Enomoto A, Murakami H, Asai N, et al. Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev Cell. 2005;9:389-402 (Pubitemid 41235808)
9. Anai M, Shojima N, Katagiri H, et al. A novel protein kinase B (PKB)/AKT-binding protein enhances PKB kinase activity and regulates DNA synthesis. J Biol Chem. 2005;280:18525-18535 (Pubitemid 41389103)
10. Jiang P, Enomoto A, Jijiwa M, et al. An actin-binding protein Girdin regulates the motility of breast cancer cells. Cancer Res. 2008;68:1310-1318 (Pubitemid 351346837)
11. Kitamura T, Asai N, Enomoto A, et al. Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat Cell Biol. 2008;10:329-337 (Pubitemid 351331020)
12. Ghosh P, Beas A, Bornheimer SJ, et al. A Gi-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate. Mol Biol Cell. 2010;21:2338-2354
13. Yun L, Ping J, Su-Ping C, et al. Clinical implications for Girdin protein expression in breast cancer. Cancer Investigation. 2011;29:405-410
14. Liu C, Zhang Y, Xu H, et al. Girdin protein: a new potential distant metastasis predictor of breast cancer. Med Oncol. 2012;29:1554-1560
15. Mikel GM, Barbara HJ, Jason E, Betty C, et al. Expression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer. FASEB J. 2011;25:590-599
16. Stephen BE, David RB, Carolyn CC, et al. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer-Verlag; 2009
17. Griffin MC, Robinson RA, Trask DK. Validation of tissue microarrays using p53 immunohistochemical studies of squamous cell carcinoma of the larynx. Mod Pathol. 2003;16:1181-1188 (Pubitemid 38018598)
18. Natsume A, Kato T, Kinjo S, et al. Girdin maintains the stemness of glioblastoma stem cells. Oncogene. 2012;31:2715-2724
19. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331:1559-1564
20. Rimm DL, Camp RL, Charette LA, Olsen DA, Provost E. Amplification of tissue by construction of tissue microarrays. Exp Mol Pathol. 2001;70:255-264 (Pubitemid 32607198)
21. Rimm DL, Camp RL, Charette LA, Costa J, Olsen DA, Reiss M. Tissue microarray: a new technology for amplification of tissue resources. Cancer J. 2001;7:24-31
22. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-847 (Pubitemid 28331029)
23. Rassidakis GZ, Jones D, Thomaides A, et al. Apoptotic rate in peripheral T-cell lymphomas: a study using a tissue microarray with vali-dation on full tissue sections. Am J Clin Pathol. 2002;118:328-334 (Pubitemid 37046330)
24. Gulmann C, Butler D, Kay E, Grace A, Leader M. Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology. 2003;42:70-76 (Pubitemid 36062570)
25. Leversha MA, Fielding P, Watson S, Gosney JR, Field JK. Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays. J Pathol. 2003;200:610-619. (Pubitemid 36987310)